Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and suppor...
Guardado en:
Autores principales: | Isabelle Arnet, Melina Verbeek, Birna Almarsdóttir Anna, Liese Barbier, Rhonda Clifford, Christiane Eickhoff, Kurt Hersberger, Isabelle Huys, Kenny Lee, Kritsanee Saramunee, Martin Schulz, David Zgarrick, Kati Sarnola |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60395ed6f9cd467db5386e97aee9c018 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini F, et al.
Publicado: (2018) - Pandemic Preparedness Handbook
-
Biosimilars: presumption of guilt
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2011) -
Journal of pharmacy practice and research official journal of the Society of Hospital Pharmacists of Australia.
Publicado: (2002) - Pharmacy times